Remove Cerebrovascular Disease Remove Hemorrhage Remove Thrombolysis
article thumbnail

Abstract WP288: Epidemiological Analysis of Incidence, Treatment, Mortality and Costs of Cerebrovascular Diseases in Brazil Between 2017 and 2022

Stroke Journal

Rates of Thrombolysis were alarming, but with an increasing tendency: 22969 were performed, from 1.6% Yearly costs related to these diseases increased steeply, from R$ 360,710,749.92 Data was obtained through DataSUS, a public database. were Male and 47.6% were Female. were Male and 47.6% were Female. in 2017 to 2.3% of all SAH cases).

article thumbnail

Abstract DP1: Intravenous thrombolysis for acute ischemic stroke patients with cerebral amyloid angiopathy

Stroke Journal

Background:Cerebral amyloid angiopathy (CAA) is a hemorrhagic cerebrovascular disease that is thought to be due to excess protein deposition in vessel walls that lead to fragility and increase the risk of rupture. Stroke, Volume 56, Issue Suppl_1 , Page ADP1-ADP1, February 1, 2025. 4.16], p=0.001).

article thumbnail

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science

DAIC

Image courtesy: ASA/AHA christine.book Mon, 01/22/2024 - 18:03 January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular diseases and brain health science from around the world, this year's International Stroke Conference, ISC 2024 , will be held Feb. 7-9 in Phoenix, Arizona.

Strokes 100